WeedMarketCap
Legal MapCommunity
WeedMarketCap

Cannabis market data, tracked daily.

Legal States Map 2026CommunityAboutContactPrivacy Policy

Prices may be delayed. This site is for informational purposes only and does not constitute financial advice. Cannabis stocks carry significant risk — always do your own research.

© 2026 WeedMarketCap. All rights reserved.

WeedMarketCap
Legal MapCommunity
Back to market table
ACB logo

Unranked

Aurora Cannabis Inc.

ACB · Nasdaq

$3.96

+1.80% (24h)

Last updated: 1 second ago

Market Cap

$250.71M

Volume (24h)

567.87K

Last Close (7D)

$3.96

View on TradingView
Earnings Nov 4 · in 61d

Company Profile

Exchange
Nasdaq
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,028
Website
www.auroramj.com
Country
🇨🇦 Canada

Once Canada's biggest cannabis company, Aurora has restructured into a leaner global medical cannabis operator focused on profitable sales across Europe, Australia, and selected domestic markets.

  • ✂️ Multiple rounds of restructuring and asset sales have put Aurora on a path toward sustainable profitability
  • 🌍 One of the strongest Canadian positions in German medical cannabis — Europe's largest legal market
  • 🏭 Aurora Sky mega-facility remains among the most efficient large-scale cannabis grows in Canada

Key Stats

52-Week Range
$2.56$6.67
Beta1.45
Trailing P/EN/A
Forward P/E-36.00
Trailing EPS-0.66
Avg Volume

Earnings & Analyst

Next Earnings2026-11-04
EPS EstimateN/A
Target Mean PriceN/A
RecommendationBuy
Recommendation Mean2.20

Recent SEC Filings

All filings
  • Foreign current report

    Foreign current report filed on 2026-07-23 (6-K).

    6-K

    2026-07-23

    SEC

  • Foreign current report

    Foreign current report filed on 2026-07-23 (6-K).

    6-K

    2026-07-23

    SEC

  • Foreign current report

    Foreign current report filed on 2026-07-09 (6-K).

    6-K

    2026-07-09

Frequently Asked Questions

What does Aurora Cannabis (ACB) do?

Aurora Cannabis is a Canadian licensed cannabis producer (LP) that has restructured from being Canada's largest cannabis company into a leaner global medical cannabis operator. The company focuses on producing and selling medical cannabis products in Europe, Australia, and selected domestic markets. Aurora's operations include cultivation, processing, and distribution of cannabis for medical patients. The company is known for its Aurora Sky mega-facility, which is one of the most efficient large-scale cannabis grows in Canada. Through multiple rounds of restructuring and asset sales, Aurora has aimed to achieve sustainable profitability.

What is Aurora Cannabis's business model?

Aurora Cannabis operates as a global medical cannabis producer, focusing on cultivation, processing, and distribution. The company's business model centers on supplying high-quality medical cannabis to patients in regulated markets, primarily in Europe and Australia, as well as in Canada. Aurora has shifted from a growth-at-all-costs strategy to a leaner approach emphasizing profitability. This has involved multiple rounds of restructuring and asset sales to reduce costs and optimize operations. The company leverages its large-scale cultivation facilities, such as Aurora Sky, to achieve efficiency in production. Revenue is generated through wholesale and direct-to-patient sales in medical markets.

Which markets does Aurora Cannabis serve?

Aurora Cannabis serves medical cannabis markets in Europe, Australia, and selected domestic markets in Canada. The company has a particularly strong position in Germany, which is Europe's largest legal medical cannabis market. Aurora also exports to other European countries and Australia, where medical cannabis programs are established. In Canada, the company focuses on the domestic medical market rather than the recreational segment. This geographic diversification allows Aurora to tap into multiple high-growth regions while reducing reliance on any single market.

What is Aurora Cannabis's role in the cannabis sector?

Aurora Cannabis is categorized as a Canadian licensed producer (LP), meaning it is a federally licensed cultivator, processor, and seller of cannabis in Canada. As an LP, Aurora operates under Health Canada's regulations and is authorized to produce and distribute cannabis for medical purposes. The company is one of the few Canadian LPs with a significant international presence, particularly in Europe. Aurora's role in the sector is as a global medical cannabis supplier, competing with other large LPs like Canopy Growth and Tilray. The company's focus on medical markets differentiates it from LPs that target the recreational market.

What are Aurora Cannabis's notable facilities or differentiators?

Aurora Cannabis operates the Aurora Sky mega-facility in Edmonton, Alberta, which is among the most efficient large-scale cannabis grows in Canada. This facility uses advanced automation and environmental controls to produce high-quality cannabis at scale. Another differentiator is Aurora's strong position in the German medical cannabis market, Europe's largest legal market. The company has also undergone significant restructuring, including multiple rounds of asset sales and cost-cutting, to put itself on a path toward sustainable profitability. These efforts have made Aurora a leaner operator compared to its earlier days as Canada's biggest cannabis company.

Latest News

  • Yahoo · Sep 2, 2026

    Aurora Cannabis Board Recommends Rejecting Curaleaf Bid

  • SeekingAlpha · Sep 2, 2026

    High Tide: German Expansion Just Added Another Bullish Catalyst

  • Yahoo · Sep 2, 2026

    Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders

  • Yahoo · Sep 2, 2026

    Aurora Cannabis Urges Shareholders to Reject Curaleaf's Takeover Bid

  • Benzinga · Sep 2, 2026

    Aurora Cannabis Fires Back at Curaleaf’s Hostile Takeover Bid

  • Yahoo · Sep 2, 2026

    Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk

1.46M
Enterprise Value$174.97M
Shares Outstanding63.31M

SEC

  • Foreign current report

    Foreign current report filed on 2026-07-09 (6-K).

    6-K

    2026-07-09

    SEC

  • Foreign current report

    Foreign current report filed on 2026-07-08 (6-K).

    6-K

    2026-07-08

    SEC

  • Foreign current report

    Foreign current report filed on 2026-06-11 (6-K).

    6-K

    2026-06-11

    SEC

  • Foreign current report

    Foreign current report filed on 2026-05-28 (6-K).

    6-K

    2026-05-28

    SEC

  • Foreign current report

    Foreign current report filed on 2026-05-21 (6-K).

    6-K

    2026-05-21

    SEC

  • Foreign current report

    Foreign current report filed on 2026-05-14 (6-K).

    6-K

    2026-05-14

    SEC

  • Foreign current report

    Foreign current report filed on 2026-04-28 (6-K).

    6-K

    2026-04-28

    SEC